# US 2026/0256859 A1 · Composition for preventing, ameliorating, or treating tuberculosis comprising extract of philadelphus sp. plant as active ingredient

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0256859 A1
- Document ID: US20260256859A1
- Status: Published application
- Kind: A1
- Application number: 19/490,002
- Filed: 2024-06-21
- Published: 2026-09-03
- Earliest claimed: 2023-06-21
- Assignees: Korea Institute of Oriental Medicine; Chungnam National University Hospital; The Industry & Academic Cooperation in Chungnam National University (IAC)
- Applicants: Korea Institute of Oriental Medicine; Chungnam National University Hospital; The Industry & Academic Cooperation In Chungnam National University (Iac)
- Inventors: CHANG-HWA SONG; JI-AE CHOI; TAM DOAN NGUYEN; DONG-SEON KIM; HEUNG JOO YUK; EUNJUNG SON; YUN MI LEE; YOON-YOUNG SUNG
- Web page: https://patentgrep.com/patent/US20260256859A1

## CPC

- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 31/133: having hydroxy groups, e.g. sphingosine
- A61K 31/4409: only substituted in position 4, e.g. isoniazid, iproniazid
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61P 31/06: for tuberculosis
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/51: Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition for preventing, ameliorating, or treating tuberculosis includes an extract of Philadelphus sp. plant as active ingredient. The extract of Philadelphus sp. plant significantly reduces the number of Mycobacterium tuberculosis not only in mouse bone marrow-derived macrophages but also in mouse (i.e., in vivo sample) infected with Mycobacterium tuberculosis, and it exhibits a synergistic effect on reducing the number of Mycobacterium tuberculosis when co-administered with an anti-tuberculosis agent. Therefore, the extract of Philadelphus sp. plant of the present invention can be advantageously used as an anti-tuberculosis agent.

## Claims

### Claim at position 1

-13. (canceled)

### Claim 14

A method for suppressing growth of Mycobacterium tuberculosis, the method comprising:
administering a composition comprising an extract of Philadelphus sp. plant to an animal other than human.

### Claim 15 (depends on 14)

The method of claim 14, wherein the composition further comprises an anti-tuberculosis agent.

### Claim 16 (depends on 15)

The method of claim 15, wherein the anti-tuberculosis agent is one or more selected from rifampicin, isoniazid, and ethambutol.

### Claim 17 (depends on 14)

The method of claim 14, wherein the extract of Philadelphus sp. plant is one or more selected from an extract of Philadelphus tenuifolius leaf, an extract of Philadelphus pekinensis Rupr. leaf, an extract of Philadelphus schrenkii leaf, an extract of Philadelphus seoulensis leaf, and an extract of Philadelphus schrenckii var. jackii Koehne leaf.

### Claim 18 (depends on 14)

The method of claim 14, wherein the extract of Philadelphus sp. plant is extracted using water, C1 to C4 lower alcohol, or a mixture thereof as an extraction solvent.

### Claim 19 (depends on 14)

The method of claim 14, wherein the composition is a pharmaceutical composition comprising (i) the an extract of Philadelphus sp. plant and (ii) a pharmaceutically acceptable carrier, an excipient, and/or a diluent.

### Claim 20 (depends on 14)

The method of claim 14, wherein the composition is a functional health food composition formulated in any one form selected from the group consisting of powder, granule, pill, tablet, capsule, candy, syrup, and beverage.

### Claim 21

A method for treating tuberculosis, the method comprising:
administering a composition comprising an extract of Philadelphus sp. plant to a subject in need thereof.

### Claim 22 (depends on 21)

The method of claim 21, wherein the composition further comprises an anti-tuberculosis agent.

### Claim 23 (depends on 22)

The method of claim 22, wherein the anti-tuberculosis agent is one or more selected from rifampicin, isoniazid, and ethambutol.

### Claim 24 (depends on 21)

The method of claim 21, wherein the extract of Philadelphus sp. plant is one or more selected from an extract of Philadelphus tenuifolius leaf, an extract of Philadelphus pekinensis Rupr. leaf, an extract of Philadelphus schrenkii leaf, an extract of Philadelphus seoulensis leaf, and an extract of Philadelphus schrenckii var. jackii Koehne leaf.

### Claim 25 (depends on 21)

The method of claim 21, wherein the extract of Philadelphus sp. plant is extracted using water, C1 to C4 lower alcohol, or a mixture thereof as an extraction solvent.

### Claim 26 (depends on 21)

The method of claim 21, wherein the composition is a pharmaceutical composition comprising (i) the an extract of Philadelphus sp. plant and (ii) a pharmaceutically acceptable carrier, an excipient, and/or a diluent.

### Claim 27 (depends on 21)

The method of claim 21, wherein the composition is a functional health food composition formulated in any one form selected from the group consisting of powder, granule, pill, tablet, capsule, candy, syrup, and beverage.

### Claim 28 (depends on 21)

The method of claim 21, wherein the subject is an animal, and the composition is a veterinary composition comprising the extract of Philadelphus sp. plant and an anti-tuberculosis agent.
